Indian indices declined on Tuesday as losses in banking, FMCG, metal and realty sectors overshadowed gains in IT and pharma, reflecting ongoing sector-specific investor caution amid profit-taking patterns.
Indian equities ended Tuesday in the red, with the Sensex and Nifty both losing ground as selling in banking, FMCG, metal and realty shares outweighed support from information technology and pharmaceutical stocks. According to Zee Business, the 30-share Sensex dropped 388.19 points, or 0.49%, to 78,154.25, while the Nifty fell 112.10 points, or 0.46%, to 24,471.70. The indices weakened late in the session after starting on a steadier note.
The broader mood was marked by selective buying rather than broad participation. Eternal led the gainers on the Sensex, rising 1.93%, while Infosys, Titan, HCLTech and TCS also closed higher. On the losing side, UltraTech Cement, Axis Bank, IndiGo, Bharti Airtel and M&M each fell more than 1%, with Tata Steel, ITC, Adani Ports, Power Grid and Hindustan Unilever also under pressure.
Sector performance showed the same split. Nifty IT advanced 0.61% and Nifty Pharma gained 1.03%, but Nifty FMCG dropped 1.17%, Nifty Realty slipped 0.95% and Nifty Metal fell 0.94%. Nifty Bank ended 0.42% lower, underscoring the strain in financial stocks that has repeatedly weighed on the market in recent sessions.
The latest move fits a pattern seen in recent market updates, where Indian shares have struggled when profit-taking and sector-specific weakness coincide with caution among investors. In late September 2025, reports of heavy selling in IT, FMCG and banking helped push the Nifty lower, while other sessions in December 2025 and January 2026 showed how losses in pharma, realty, metal and IT can quickly drag benchmark indices into the red. Tuesday’s trade followed that same script, with limited support from a few large technology names not enough to offset broader weakness.
Disclaimer: This article is intended to inform and educate, not to recommend or endorse any financial product, investment or strategy. Please consider your own financial circumstances and seek professional advice where appropriate before making financial decisions.
